INIS
patients
100%
drugs
68%
india
57%
reviews
39%
cancer
35%
hospitals
35%
diseases
26%
risks
26%
evaluation
23%
therapy
21%
populations
21%
levels
20%
management
20%
data
20%
interactions
19%
covid-19
19%
tuberculosis
18%
humans
17%
assessments
17%
control
16%
proteins
15%
comparative evaluations
15%
education
14%
teaching
14%
receptors
14%
information
14%
genes
13%
mortality
13%
vitamin d
12%
antibiotics
12%
medicine
11%
doses
11%
diabetes mellitus
11%
neonates
10%
breasts
10%
pharmaceuticals
10%
applications
9%
lungs
9%
performance
9%
tumors
9%
inflammation
9%
safety
9%
monitoring
8%
plasma
8%
liquids
8%
poisoning
8%
chemotherapy
7%
rats
7%
kidneys
7%
in vitro
7%
quality of life
7%
enzymes
7%
learning
7%
synthesis
7%
simulation
6%
ulcers
6%
blood
6%
values
6%
hypertension
6%
tools
6%
chromatography
6%
symptoms
6%
precision
6%
liver
6%
growth
6%
detection
6%
communities
5%
guidelines
5%
adults
5%
toxicity
5%
genetics
5%
range
5%
males
5%
design
5%
concentration
5%
prediction
5%
tobacco smokes
5%
weight
5%
testing
5%
in vivo
5%
interventions
5%
inhibition
5%
utilities
5%
Medicine and Dentistry
Patient
33%
Tertiary Care
13%
Inpatient
12%
Hospital
12%
Therapeutic Procedure
11%
COVID-19
10%
Assessment
6%
Meta-Analysis
6%
Tuberculosis
6%
Diabetic Foot Ulcer
6%
Mortality
6%
Diabetes
5%
Systematic Review
5%
Vitamin D
5%
Quality of Life
5%
Maturity Onset Diabetes of the Young
5%
Association
5%
Supplementation
5%
Infection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
24%
Pharmacokinetics
17%
Pharmacology
8%
Mortality
7%
Antibiotics
6%
Observational Study
6%
Drug-Drug Interaction
6%
Adverse Drug Reaction
5%
High Performance Liquid Chromatography
5%
Antibiotic Agent
5%
Non Insulin Dependent Diabetes Mellitus
5%
Hypertension
5%
Diabetes Mellitus
5%
Toxic Injury
5%
Diseases
5%
Antiinfective Agent
5%
Vitamin D
5%
Breast Cancer
5%
Tuberculosis
5%
Drug Interaction
5%
Adverse Event
5%